These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16102092)

  • 41. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease.
    Casonato A; Pontara E; Bertomoro A; Zucchetto A; Zerbinati A; Girolami A
    Br J Haematol; 1995 Oct; 91(2):512-3. PubMed ID: 8547104
    [No Abstract]   [Full Text] [Related]  

  • 43. New variant of von Willebrand disease with defective binding to factor VIII.
    Nishino M; Girma JP; Rothschild C; Fressinaud E; Meyer D
    Blood; 1989 Oct; 74(5):1591-9. PubMed ID: 2506947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. When von Willebrand disease comes into age - a matter of change?
    Miesbach W; Berntorp E
    Eur J Haematol; 2011 Jun; 86(6):496-501. PubMed ID: 21418329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. von Willebrand factor: the new treatment paradigm--introduction.
    Lee CA; Montgomery RR
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S1-2. PubMed ID: 15849520
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the in vivo survival of human factor VIII with and without von Willebrand factor in the hemophilic dog.
    Fay PJ; Cavallaro C; Marder VJ; Pancham N; Fournel MA; Schroeder DD
    Thromb Res; 1986 Feb; 41(3):425-9. PubMed ID: 3085273
    [No Abstract]   [Full Text] [Related]  

  • 47. In search of the eighth factor: a personal reminiscence.
    Tuddenham EG
    J Thromb Haemost; 2003 Mar; 1(3):403-9. PubMed ID: 12871437
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of von Willebrand's Disease.
    Mannucci PM
    N Engl J Med; 2004 Aug; 351(7):683-94. PubMed ID: 15306670
    [No Abstract]   [Full Text] [Related]  

  • 49. Laboratory diagnosis of von Willebrand disease.
    Roberts JC; Flood VH
    Int J Lab Hematol; 2015 May; 37 Suppl 1(Suppl 1):11-7. PubMed ID: 25976955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery.
    Berger J; Schwartz J; Ramachandran S; Leff JD
    J Cardiothorac Vasc Anesth; 2019 Dec; 33(12):3446-3457. PubMed ID: 31570241
    [No Abstract]   [Full Text] [Related]  

  • 51. Reactions of thrombin with human factor VIII/von Willebrande factor protein.
    Switzer ME; McKee PA
    J Biol Chem; 1980 Nov; 255(22):10606-11. PubMed ID: 6776120
    [No Abstract]   [Full Text] [Related]  

  • 52. Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.
    Ebberink EH; Bouwens EA; Bloem E; Boon-Spijker M; van den Biggelaar M; Voorberg J; Meijer AB; Mertens K
    Haematologica; 2017 Apr; 102(4):686-694. PubMed ID: 28057741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
    Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
    Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment.
    Jorieux S; Fressinaud E; Goudemand J; Gaucher C; Meyer D; Mazurier C
    Blood; 2000 May; 95(10):3139-45. PubMed ID: 10807780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abstracts of a symposium on "Factor VIII/von Willebrand Factor, Platelet Formation, and Function in Health and Disease: A Tribute to Dr. Marion I. Barnhart". Detroit, Michigan, November 21 and 22, 1986.
    Semin Thromb Hemost; 1987 Apr; 13(2):228-37. PubMed ID: 3114889
    [No Abstract]   [Full Text] [Related]  

  • 56. Interaction of factor VIII and von Willebrand factor and the identification of type 2N von Willebrand disease.
    Favaloro EJ
    Thromb Res; 2011 Jan; 127(1):2-3. PubMed ID: 21084106
    [No Abstract]   [Full Text] [Related]  

  • 57. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.
    Nishino M; Miura S; Yoshioka A; Kuwahara I; Nishimura T; Hamada K; Fukui H
    Int J Hematol; 1993 Apr; 57(2):163-73. PubMed ID: 8494994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor.
    Dagil L; Troelsen KS; Bolt G; Thim L; Wu B; Zhao X; Tuddenham EGD; Nielsen TE; Tanner DA; Faber JH; Breinholt J; Rasmussen JE; Hansen DF
    Biophys J; 2019 Aug; 117(3):479-489. PubMed ID: 31349985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction between VWF and FVIII in treating VWD.
    Miesbach W; Berntorp E
    Eur J Haematol; 2015 Nov; 95(5):449-54. PubMed ID: 25605439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P) in von Willebrand disease and haemophilia A: a viewpoint by Eric Berntorp.
    Berntorp E
    Drugs; 2007; 67(10):1520. PubMed ID: 17600396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.